MHC class I and II-deficient humanized mice are suitable tools to test the long-term antitumor efficacy of immune checkpoint inhibitors and T-cell engagers

1. Eguren-Santamaria, I.
2. Fernández de Piérola, E.
3. Camps, G.
4. Martín-Muñoz, P.
5. Campos, M.
6. Cuculescu, D.
7. Aguilera-Buenosvinos, I.
8. Rodríguez López, I.
9. Salido-Vallejo, R.
10. Alexandru, R.
11. De Andrea, C.E.
12. Álvarez-Gigli, L.
13. Berraondo, P.
14. Melero, I.
15. Sanmamed, M.F.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1136/JITC-2023-008516 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus